BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32386029)

  • 21. A novel subclonal rearrangement of the STRN3::PDGFRB gene in de novo acute myeloid leukemia with NPM1 mutation and its leukemogenic effects.
    Wang Z; Liu T; Liu W; Gao X; Wan L; Qiu S; Song Y; Gu R; Tian Z; Wang M; Wang J; Mi Y; Wei S
    Cancer Gene Ther; 2023 Nov; 30(11):1471-1484. PubMed ID: 37550570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myeloid neoplasm with ETV6::ACSl6 fusion: landscape of molecular and clinical features.
    Su Z; Liu X; Hu W; Yang J; Yin X; Hou F; Wang Y; Zhang J
    Hematology; 2022 Dec; 27(1):1010-1018. PubMed ID: 36069745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myeloid neoplasm with eosinophilia and rearrangement of platelet-derived growth factor receptor beta gene in children: Two case reports.
    Wang SC; Yang WY
    World J Clin Cases; 2021 Jan; 9(1):204-210. PubMed ID: 33511186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of myeloid neoplasm associated with eosinophilia and KIAA1509-PDGFRβ responsive to combination treatment with imatinib mesylate and prednisolone.
    Wang JR; Yen CC; Gau JP; Hsiao LT; Liu CY; Pai JT; Tzeng CH; Teng HW
    J Clin Pharm Ther; 2010 Dec; 35(6):733-6. PubMed ID: 21054467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pseudo-Gaucher cells in a myeloid neoplasm with PDGFRB rearrangement: imitating the imitator.
    Cho-Vega JH; Loghavi S
    Blood; 2022 Aug; 140(6):664. PubMed ID: 35951342
    [No Abstract]   [Full Text] [Related]  

  • 26. Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1.
    Patterer V; Schnittger S; Kern W; Haferlach T; Haferlach C
    Ann Hematol; 2013 Jun; 92(6):759-69. PubMed ID: 23400675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic and clinical findings in myeloid neoplasms with PDGFRB rearrangement.
    Di Giacomo D; Quintini M; Pierini V; Pellanera F; La Starza R; Gorello P; Matteucci C; Crescenzi B; Fiumara PF; Veltroni M; Borlenghi E; Albano F; Forghieri F; Maccaferri M; Bettelli F; Luppi M; Cuneo A; Rossi G; Mecucci C
    Ann Hematol; 2022 Feb; 101(2):297-307. PubMed ID: 34859285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel translocations that disrupt the platelet-derived growth factor receptor beta (PDGFRB) gene in BCR-ABL-negative chronic myeloproliferative disorders.
    Baxter EJ; Kulkarni S; Vizmanos JL; Jaju R; Martinelli G; Testoni N; Hughes G; Salamanchuk Z; Calasanz MJ; Lahortiga I; Pocock CF; Dang R; Fidler C; Wainscoat JS; Boultwood J; Cross NC
    Br J Haematol; 2003 Jan; 120(2):251-6. PubMed ID: 12542482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA Sequencing Analysis for the Identification of a PCM1/PDGFRB Fusion Gene Responsive to Imatinib.
    Such E; Liquori A; Mora E; Marco-Ayala J; Avetisyan G; Regadera A; Ibañez F; Panadero J; Senent L; Llop M; Díaz A; Vicente A; Luna I; Ibáñez M; Barragán E; Sanz MA; Sanz G; Communidad Valenciana ; Cervera J
    Acta Haematol; 2019; 142(2):92-97. PubMed ID: 31085913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PDGFRᵝ-Rearranged Myeloid Neoplasm with Marked Eosinophilia in a 37-Year-Old Man; And a Literature Review.
    Andrei M; Bandarchuk A; Abdelmalek C; Kundra A; Gotlieb V; Wang JC
    Am J Case Rep; 2017 Feb; 18():173-180. PubMed ID: 28209946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of three new imatinib-responsive fusion genes in chronic myeloproliferative disorders generated by disruption of the platelet-derived growth factor receptor beta gene.
    Walz C; Metzgeroth G; Haferlach C; Schmitt-Graeff A; Fabarius A; Hagen V; Prümmer O; Rauh S; Hehlmann R; Hochhaus A; Cross NC; Reiter A
    Haematologica; 2007 Feb; 92(2):163-9. PubMed ID: 17296564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myeloid/Lymphoid Neoplasms with
    Gou Y; Tang Y; Liu S; Cheng S; Deng X; Wen Q; Feng Y; Peng X; Wang P; Zhang X
    J Inflamm Res; 2023; 16():5163-5170. PubMed ID: 38026242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal mast cells in myeloid neoplasm with eosinophilia and PDGFRB rearrangement.
    Bourrienne MC; Debus J
    Blood; 2019 Aug; 134(8):718. PubMed ID: 31439618
    [No Abstract]   [Full Text] [Related]  

  • 34. Myeloid tumors accompanying systemic mastocytosis, basophilia, and abnormal platelet-derived growth factor receptor β: A case report.
    Li Y; Jing Y; Wan H; Liu D
    Medicine (Baltimore); 2021 Feb; 100(8):e24707. PubMed ID: 33663081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myeloproliferative disorders with translocations of chromosome 5q31-35: role of the platelet-derived growth factor receptor Beta.
    Steer EJ; Cross NC
    Acta Haematol; 2002; 107(2):113-22. PubMed ID: 11919393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted next generation sequencing of PDGFRB rearranged myeloid neoplasms with monocytosis.
    Patnaik MM; Lasho TL; Finke CM; Pardanani A; Tefferi A
    Am J Hematol; 2016 Mar; 91(3):E12-4. PubMed ID: 26662677
    [No Abstract]   [Full Text] [Related]  

  • 37. Incidence and clinical characteristics of myeloproliferative neoplasms displaying a PDGFRB rearrangement.
    Arefi M; García JL; Peñarrubia MJ; Queizán JA; Hermosín L; López-Corral L; Megido M; Giraldo P; de las Heras N; Vanegas RJ; Gutiérrez NC; Hernández-Rivas JM
    Eur J Haematol; 2012 Jul; 89(1):37-41. PubMed ID: 22587685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NIN, a gene encoding a CEP110-like centrosomal protein, is fused to PDGFRB in a patient with a t(5;14)(q33;q24) and an imatinib-responsive myeloproliferative disorder.
    Vizmanos JL; Novo FJ; Román JP; Baxter EJ; Lahortiga I; Larráyoz MJ; Odero MD; Giraldo P; Calasanz MJ; Cross NC
    Cancer Res; 2004 Apr; 64(8):2673-6. PubMed ID: 15087377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myeloid neoplasm with prominent eosinophilia and PDGFRA rearrangement treated with imatinib mesylate.
    Rathe M; Kristensen TK; Møller MB; Carlsen NL
    Pediatr Blood Cancer; 2010 Oct; 55(4):730-2. PubMed ID: 20589620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A cryptic imatinib-sensitive G3BP1-PDGFRB rearrangement in a myeloid neoplasm with eosinophilia.
    Jan M; Grinshpun DE; Villalba JA; Dal Cin P; Sykes DB; Iafrate AJ; Ebert BL; Hobbs GS; Nardi V
    Blood Adv; 2020 Feb; 4(3):445-448. PubMed ID: 31999327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.